<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="case-report" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12429793</article-id><article-id pub-id-type="pmcid-ver">PMC12429793.1</article-id><article-id pub-id-type="pmcaid">12429793</article-id><article-id pub-id-type="pmcaiid">12429793</article-id><article-id pub-id-type="doi">10.3390/jcm14176032</article-id><article-id pub-id-type="publisher-id">jcm-14-06032</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Late Recurrence of High-Grade Vulvar Leiomyosarcoma After 5 Years: A Rare Case Report and Expanded Review of Reported Cases</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7719-382X</contrib-id><name name-style="western"><surname>Yordanov</surname><given-names initials="A">Angel</given-names></name><xref rid="af1-jcm-14-06032" ref-type="aff">1</xref><xref rid="c1-jcm-14-06032" ref-type="corresp">*</xref><xref rid="fn1-jcm-14-06032" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ivanov</surname><given-names initials="I">Ivan</given-names></name><xref rid="af2-jcm-14-06032" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5279-3095</contrib-id><name name-style="western"><surname>Kostov</surname><given-names initials="S">Stoyan</given-names></name><xref rid="af3-jcm-14-06032" ref-type="aff">3</xref><xref rid="af4-jcm-14-06032" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hasan</surname><given-names initials="I">Ihsan</given-names></name><xref rid="af5-jcm-14-06032" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dimitrova</surname><given-names initials="V">Vasilena</given-names></name><xref rid="af6-jcm-14-06032" ref-type="aff">6</xref><xref rid="c1-jcm-14-06032" ref-type="corresp">*</xref><xref rid="fn1-jcm-14-06032" ref-type="author-notes">&#8224;</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Sperti</surname><given-names initials="C">Cosimo</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-14-06032"><label>1</label>Department of Gynaecological Oncology, Medical University Pleven, 5800 Pleven, Bulgaria</aff><aff id="af2-jcm-14-06032"><label>2</label>Department of General and Clinical Pathology, University Hospital &#8220;Dr. Georgi Stranski&#8221;, 5800 Pleven, Bulgaria; <email>posledenzalez@gmail.com</email></aff><aff id="af3-jcm-14-06032"><label>3</label>Department of Gynaecology, St. Anna University Hospital, 9002 Varna, Bulgaria; <email>drstoqn.kostov@gmail.com</email></aff><aff id="af4-jcm-14-06032"><label>4</label>Research Institute, Medical University Pleven, 5800 Pleven, Bulgaria</aff><aff id="af5-jcm-14-06032"><label>5</label>Department of Obstetrics and Gynecology, University Hospital &#8220;Sofiamed&#8221;, 1000 Sofia, Bulgaria; <email>ihsan_hasanov@abv.bg</email></aff><aff id="af6-jcm-14-06032"><label>6</label>Faculty of Medicine, Medical University Pleven, 5800 Pleven, Bulgaria</aff><author-notes><corresp id="c1-jcm-14-06032"><label>*</label>Correspondence: <email>angel.jordanov@gmail.com</email> (A.Y.); <email>vasilenadimitrova4@gmail.com</email> (V.D.)</corresp><fn id="fn1-jcm-14-06032"><label>&#8224;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>14</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496787</issue-id><elocation-id>6032</elocation-id><history><date date-type="received"><day>08</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>11</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-14-06032.pdf"/><abstract><p><bold>Background:</bold> Vulvar leiomyosarcoma (VLMS) is a rare and aggressive soft tissue malignancy arising from smooth muscle cells, comprising less than 3% of vulvar cancers. Its clinical resemblance to benign vulvar lesions often leads to delayed diagnosis. Despite surgical resection and adjuvant therapy, VLMS is associated with high recurrence rates and a poor prognosis, and due to its rarity, there is no standardized management or surveillance protocol. <bold>Case Report:</bold> We present a case of high-grade VLMS in a postmenopausal woman, initially diagnosed in 2020 and managed with surgical excision and adjuvant radiotherapy. The primary tumor was a 10 cm solid, lobulated mass involving the mons pubis, with histology confirming high-grade leiomyosarcoma based on marked cellular atypia, high mitotic activity, and smooth muscle differentiation. Immunohistochemistry was positive for SMA, vimentin, and CD34, and negative for S100 and MyoD1. Five years later, the patient developed a local recurrence with an enlarged inguinal lymph node. She underwent complete tumor resection and bilateral inguinal lymphadenectomy. Histology of the recurrent lesion mirrored the initial findings, with no lymph node metastases. This case highlights the aggressive nature and potential for late recurrence in vulvar leiomyosarcoma, underscoring the importance of long-term surveillance. <bold>Conclusions:</bold> High-grade VLMS is a rare malignancy with a high recurrence risk. This case highlights the importance of early diagnosis, radical surgical treatment, and long-term surveillance. Although recurrence occurred five years after the initial treatment, timely surgical intervention led to a favorable postoperative course. Multidisciplinary management and individualized follow-up strategies remain key to improving outcomes in these rare gynecologic sarcomas.</p></abstract><kwd-group><kwd>vulvar leiomyosarcoma</kwd><kwd>recurrence</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-14-06032"><title>1. Introduction</title><p>Vulvar leiomyosarcoma (VLMS) is an exceptionally rare and aggressive malignancy derived from smooth muscle cells, accounting for less than 3% of vulvar cancers and an even smaller proportion of all gynecologic malignancies [<xref rid="B1-jcm-14-06032" ref-type="bibr">1</xref>]. While the majority of vulvar tumors are benign (e.g., Bartholin gland cysts, fibromas, or lipomas), LMS can clinically mimic benign lesions due to its slow, painless growth in the early stages, resulting in frequent delays in diagnosis and treatment. Histologically, it is characterized by spindle-shaped cells with eosinophilic cytoplasm and pleomorphic nuclei, arranged in fascicles, often demonstrating high mitotic activity and areas of necrosis [<xref rid="B1-jcm-14-06032" ref-type="bibr">1</xref>].</p><p>Despite complete surgical excision and adjuvant therapy, vulvar LMS is notorious for local recurrence, potential for late metastasis, and poor overall prognosis [<xref rid="B2-jcm-14-06032" ref-type="bibr">2</xref>]. The rarity of the disease results in a lack of standardized treatment protocols and limited consensus on optimal surveillance strategies [<xref rid="B2-jcm-14-06032" ref-type="bibr">2</xref>]. Therefore, each reported case adds meaningful data to the sparse literature, helping shape future clinical decision-making.</p><p>This case report describes a rare instance of recurrent high-grade VLMS occurring five years after the initial curative surgery and adjuvant radiotherapy in 2020 in a postmenopausal woman, as reported by Yordanov et al. [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. It analyzes the diagnostic challenges, histopathologic features, and immunohistochemical profile of both the primary and recurrent tumor, evaluating any phenotypic changes over time. Furthermore, it presents a comprehensive review of published VLMS cases from the past four decades, examining recurrence patterns, treatment approaches and prognostic factors, with the aim of offering practical recommendations for clinical management and long-term follow-up.</p></sec><sec id="sec2-jcm-14-06032"><title>2. Case Report</title><p>Initial diagnosis and treatment in 2020, a 74-year-old postmenopausal white woman, with no significant comorbidities other than arterial hypertension and a prior cholecystectomy (2006), presented with a painful, enlarging mass of the mons pubis, measuring 10 cm in diameter (<xref rid="jcm-14-06032-f001" ref-type="fig">Figure 1</xref>A) [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. She reported severe pain, partially relieved by analgesics, but denied vaginal bleeding or discharge [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>].</p><p>Upon examination, a lobulated, mobile, subcutaneous tumor was noted, infiltrating the overlying skin, but not fixed to deep structures. The rest of the gynecological exam was unremarkable.</p><p>She underwent wide local excision. Intraoperatively, a solid, lobulated tumor measuring approximately 10 &#215; 10 cm was excised from the symphysis with macroscopically and microscopically clear margins. The wound was repaired in two layers, and the patient had an uncomplicated recovery.</p><p>Postoperative recovery was uneventful and the patient began adjuvant radiotherapy five weeks after surgery. Following surgery, the patient received adjuvant radiotherapy consisting of two courses of deep X-ray therapy. The first course delivered 30 Gy as five fractions of 400 R, and the second course delivered 20 Gy as four fractions of 400 R. She completed radiotherapy without complications and remained clinically disease-free for five years.</p><p>Five years post-surgery, the patient presented with a recurrent tumor in the mons pubis area, accompanied by an enlarged left inguinal lymph node. A clinical exam confirmed a solid, lobulated formation measuring ~15 &#215; 10 cm and a palpable left inguinal mass (<xref rid="jcm-14-06032-f001" ref-type="fig">Figure 1</xref>B&#8211;D). Preoperative ultrasound, Doppler ultrasound, and PET-CT were performed.</p><p>The ultrasound image shows a well-defined structure with dimensions of approximately 6.18 cm in length and 3.78 cm in width. It appears as a relatively hypoechoic area, darker than the surrounding tissue (<xref rid="jcm-14-06032-f002" ref-type="fig">Figure 2</xref>A). The lymph node ultrasound image reveals a small, well-defined structure measuring approximately 2.47 cm in length and 2.00 cm in width, consistent with an enlarged lymph node. The node is relatively hypoechoic and oval in shape, suggesting a reactive or possibly pathological nature (<xref rid="jcm-14-06032-f002" ref-type="fig">Figure 2</xref>C). A Doppler ultrasound was also performed to further assess vascular characteristics of the tumor formation (<xref rid="jcm-14-06032-f002" ref-type="fig">Figure 2</xref>B) and the lymph node (<xref rid="jcm-14-06032-f002" ref-type="fig">Figure 2</xref>D).</p><p>PET-CT shows increased uptake in the symphysis and left pelvic regions, consistent with pathological lymphadenopathy, likely involving the inguinal lymph nodes. No other abnormal metabolic activity is noted (<xref rid="jcm-14-06032-f003" ref-type="fig">Figure 3</xref>).</p><p>She underwent surgical excision of the recurrent vulvar tumor (complete extirpation of the mons pubis tumor with a 2 cm safety margin) and bilateral inguinal lymphadenectomy (<xref rid="jcm-14-06032-f004" ref-type="fig">Figure 4</xref>A&#8211;C). The tumor was solid, lobulated, and yellow-gray on the cut section with a lipomatous appearance (<xref rid="jcm-14-06032-f004" ref-type="fig">Figure 4</xref>C). The overlying skin was not involved, and both the deep and lateral resection margins were free of tumor infiltration. No intraoperative complications; the defect was closed primarily using layered sutures without the use of a flap, wound closure and drainage were completed successfully.</p><p>The patient recovered well postoperatively, with no fever, no wound complications, and spontaneous micturition and defecation restored.</p><p>Histologically, the morphology of the recurrent tumor closely resembled the primary lesion from 2020, confirming the diagnosis of recurrent high-grade leiomyosarcoma [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. The recurrent surgical specimen, consisted of a wide local resection encompassing the entire mons pubis and surrounding soft tissues, measuring 150 &#215; 150 mm in total area. Multiple tumor nodules were identified within the subcutaneous tissue, the largest measuring approximately 50&#8211;60 mm. On the cut surface, the tumor was solid, lobulated, and yellow-gray in appearance with a fatty texture. There was no involvement of the overlying skin grossly. The deep and lateral margins appeared uninvolved by tumor upon gross examination.</p><p>Also included in the resection were bilateral inguinal lymph node packages. The left inguinal region contained a notably enlarged lymph node measuring 25 &#215; 20 mm, while other nodes appeared unremarkable.</p><p>Microscopically, the morphology of the recurrent tumor closely resembled the primary leiomyosarcoma excised in 2020, as presented in <xref rid="jcm-14-06032-f005" ref-type="fig">Figure 5</xref>A&#8211;D [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. The tumor consisted of densely cellular, intersecting fascicles composed of spindle-shaped cells with marked nuclear pleomorphism, coarse and irregular chromatin, and prominent nucleoli. The cytoplasm was eosinophilic and moderate in volume, consistent with smooth muscle differentiation. The tumor exhibited high mitotic activity, with numerous mitoses per high-power field, including atypical forms. Scattered areas of coagulative tumor necrosis were present, as well as foci of peritumoral fibrosis. No lymphovascular invasion was identified in the histological specimen.</p><p>The resection margins&#8212;both lateral and deep&#8212;were histologically free of tumor cells. There was no direct extension or presence of tumor infiltration observed in the resection margins. The resection line was at least 20 mm away from the tumor infiltration front. The dermis and epidermis overlying the tumor were not involved, consistent with the absence of skin infiltration observed grossly.</p><p>A total of five inguinal lymph nodes were examined. All demonstrated reactive follicular hyperplasia and sinus histiocytosis, with no evidence of metastatic tumor involvement in either the left or right inguinal regions.</p><p>Immunohistochemical staining of the recurrent lesion confirmed a consistent profile with the primary tumor from 2020 [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. In both specimens, tumor cells showed: Smooth Muscle Actin (SMA)&#8211;strong, diffuse positivity, confirming smooth muscle differentiation; Vimentin (+) positive, indicating mesenchymal origin; CD34 local positivity; while not specific, this marker is occasionally expressed in soft tissue sarcomas; S100 Protein (-) negative; effectively excluding tumors of neural crest origin such as malignant peripheral nerve sheath tumors or melanoma; MyoD1 (&#8722;) negative; ruling out rhabdomyoblastic differentiation. In the 2020 specimen, CD68 demonstrated focal positivity, likely indicative of background histiocytic activity rather than neoplastic expression [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. This was not a significant feature in the 2025 recurrence.</p><p>The immunophenotype of the recurrent lesion also demonstrated somewhat partial loss of specific smooth muscle differentiation, with evident but aberrant positivity for alpha-SMA (<xref rid="jcm-14-06032-f006" ref-type="fig">Figure 6</xref>A) and a current lack of Desmin expression (<xref rid="jcm-14-06032-f006" ref-type="fig">Figure 6</xref>B). MyoD1 remained negative (<xref rid="jcm-14-06032-f006" ref-type="fig">Figure 6</xref>C). The current appearance and differentiation closely resemble that of undifferentiated pleomorphic sarcoma.</p><p>The immunophenotype remained stable over time, with no significant phenotypic shifts observed between the initial tumor and the recurrence. These findings support the diagnosis of recurrent high-grade leiomyosarcoma with smooth muscle differentiation.</p><p>Adjuvant therapy was reinitiated in 2025, but treatment was interrupted after one month due to the development of radiodermatitis and mucoid reactions, limiting the tolerability of further radiotherapy at that time.</p></sec><sec sec-type="discussion" id="sec3-jcm-14-06032"><title>3. Discussion</title><p>A literature search was performed to provide an overview of all the cases and case characteristics of VLMS described in the literature. We conducted a search in the PubMed<sup>&#174;</sup> database from the years 1984 to 2025 for the terms &#8220;vulva AND leiomyosarcoma&#8221;. This yielded a total of 139 citations. Based on the article type filter-case report, we excluded 65 of them. Of the remaining 74, only 24 meeting the criteria. Thus, a total of 24 publications on LMS of the vulva were taken into account to use for the discussion and review of literature, including the table of literature (<xref rid="jcm-14-06032-f007" ref-type="fig">Figure 7</xref>).</p><p>The clinical data and characteristics of the VLMS database are summarized in <xref rid="jcm-14-06032-t001" ref-type="table">Table 1</xref> [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>,<xref rid="B4-jcm-14-06032" ref-type="bibr">4</xref>,<xref rid="B5-jcm-14-06032" ref-type="bibr">5</xref>,<xref rid="B6-jcm-14-06032" ref-type="bibr">6</xref>,<xref rid="B7-jcm-14-06032" ref-type="bibr">7</xref>,<xref rid="B8-jcm-14-06032" ref-type="bibr">8</xref>,<xref rid="B9-jcm-14-06032" ref-type="bibr">9</xref>,<xref rid="B10-jcm-14-06032" ref-type="bibr">10</xref>,<xref rid="B11-jcm-14-06032" ref-type="bibr">11</xref>,<xref rid="B12-jcm-14-06032" ref-type="bibr">12</xref>,<xref rid="B13-jcm-14-06032" ref-type="bibr">13</xref>,<xref rid="B14-jcm-14-06032" ref-type="bibr">14</xref>,<xref rid="B15-jcm-14-06032" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-06032" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-06032" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-06032" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-06032" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-06032" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-06032" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-06032" ref-type="bibr">22</xref>,<xref rid="B23-jcm-14-06032" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-06032" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-06032" ref-type="bibr">25</xref>].</p><p>VLMS is a rare malignancy, with only 28 well-documented cases published in the literature between 1980 and 2025. An analysis of these cases reveals several clinical patterns, particularly concerning recurrence risk, tumor behavior, and management outcomes.</p><p>Our current case represents a recurrence of the tumor first, described by Yordanov et al. in 2020, five years after the original diagnosis [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]. This recurrence highlights the latent and unpredictable nature of VLMS. While the majority of documented recurrences occur within the first 2&#8211;3 years post-treatment, a few cases&#8212;including ours&#8212;demonstrate that VLMS can recur after prolonged disease-free intervals, underscoring the importance of long-term surveillance.</p><p>From the 28 reviewed cases, recurrence was noted in nine patients. Among those, five experienced multiple recurrences, with at least three ultimately succumbing to the disease. Recurrence was often associated with larger tumors (&#8805;8 cm). The mean size of tumors that recurred was approximately 8.5 cm, while non-recurrent tumors averaged closer to 5.2 cm, suggesting a correlation between tumor size and recurrence risk.</p><p>Metastasis was less common, reported in 6 out of the 28 cases, typically involving the lungs. Interestingly, even large tumors did not universally metastasize, suggesting variable biological behavior. Notably, the current case presented a substantial recurrence (15 &#215; 10 cm), yet without nodal or distant metastasis, aligning with prior reports that VLMS tends to recur locally before systemic spread.</p><p>Treatment strategies varied widely. Most patients underwent surgical excision, ranging from simple tumorectomy (TE) to radical vulvectomy with bilateral lymph node dissection (BILND). Unfortunately, most authors have described their surgical interventions without specifying the safety margins, which are crucial to assess given the rarity of the disease and their importance in predicting patient outcomes. Adjuvant radiotherapy and chemotherapy were employed inconsistently, with no consensus on effectiveness. Cases with radical excision appeared to have better outcomes. In our case, both the primary and recurrent tumors were managed surgically with macroscopically complete resection and histologically negative margins.</p><p>Histologically, the recurrent tumor mirrored the initial lesion, demonstrating consistent morphology and immunophenotype across the five-year interval. This lack of dedifferentiation suggests a stable tumor biology in this case. The immunophenotype, although somewhat discrepant with the commonly expected for leiomyosarcoma is consistent with the dedifferentiation observed in leiomyosarcoma of the uterine corpus in the context of tumor progression [<xref rid="B26-jcm-14-06032" ref-type="bibr">26</xref>]. According to the present case, dedifferentiation during tumor progression can be observed in the context of leiomyosarcoma of the vulva. Such phenotypic stability, though not universal, may correlate with lower metastatic potential.</p><p>Demographically, most affected individuals were postmenopausal women aged 45&#8211;74. The most common presenting symptoms included a painless or painful vulvar mass, with occasional lymphadenopathy or skin involvement. However, the clinical resemblance to benign lesions often delayed diagnosis.</p><p>Overall, this case contributes to the increasing amount of data indicating that, even in cases that were first thought to be cured, VLMS has a significant risk of late recurrence. It also supports the idea that aggressive surgical management can achieve long-term control, especially when combined with vigilant long-term follow-up.</p><p>There is not a systematic approach for the management and follow-up of VLMS because of the small number of patients and the variation in presentation and prognosis. Further multicenter collaboration and centralized case registries may improve our understanding of VLMS and help develop evidence-based guidelines for optimal care.</p></sec><sec sec-type="conclusions" id="sec4-jcm-14-06032"><title>4. Conclusions</title><p>High-grade VLMS remains a rare and aggressive malignancy with a notable risk for delayed recurrence. This case, representing a five-year recurrence of a previously reported tumor, demonstrates the necessity for extended surveillance even in the absence of early relapse. The consistent histopathologic features over time, absence of metastasis, and successful surgical re-excision suggest that timely detection and multidisciplinary management can still yield favorable outcomes. This case reinforces the importance of individualized follow-up strategies in VLMS and contributes to the sparse long-term data available for this disease.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.Y. and V.D.; methodology, I.H. and S.K.; formal analysis, I.I.; investigation, V.D. and S.K.; resources, V.D. and I.I.; data curation: I.H.; writing&#8212;original and draft preparation: V.D.; writing&#8212;review and editing, A.Y.; visualization, I.I. and I.H.; supervision, A.Y. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted in accordance with the Declaration of Helsinki. The ethical approval has been waived by the Institutional Review Board of Medical University Pleven for reporting individual cases or case series when informed consent is provided by the patient.</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent has been obtained from the patient to publish this paper.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data presented in this study are available upon request from the corresponding author due to privacy concerns.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-14-06032"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chokoeva</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Tchernev</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Dechev</surname><given-names>I.</given-names></name><name name-style="western"><surname>Valkanov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zanardelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lotti</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wollina</surname><given-names>U.</given-names></name></person-group><article-title>Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 1</article-title><source>Int. J. Immunopathol. Pharmacol.</source><year>2015</year><volume>28</volume><fpage>168</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1177/0394632015576029</pub-id><pub-id pub-id-type="pmid">25816394</pub-id></element-citation></ref><ref id="B2-jcm-14-06032"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korkmaz</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kurdo&#287;lu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kardag</surname><given-names>B.</given-names></name><name name-style="western"><surname>Arslanca</surname><given-names>T.</given-names></name><name name-style="western"><surname>Caydere</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ergun</surname><given-names>Y.</given-names></name></person-group><article-title>A rare case of leiomyosarcoma localized in the Bartholin&#8217;s gland area and review of the literature</article-title><source>J. Obstet. Gynaecol. Res.</source><year>2016</year><volume>42</volume><fpage>589</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1111/jog.12943</pub-id><pub-id pub-id-type="pmid">26889877</pub-id></element-citation></ref><ref id="B3-jcm-14-06032"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yordanov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Slavchev</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kostov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Strashilov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nikolova</surname><given-names>M.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva: A case report</article-title><source>Prz Menopauzalny</source><year>2020</year><volume>19</volume><fpage>184</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.5114/pm.2020.101949</pub-id><pub-id pub-id-type="pmid">33488330</pub-id><pub-id pub-id-type="pmcid">PMC7812529</pub-id></element-citation></ref><ref id="B4-jcm-14-06032"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Audet-Lapointe</surname><given-names>P.</given-names></name><name name-style="western"><surname>Paquin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guerard</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Charbonneau</surname><given-names>A.</given-names></name><name name-style="western"><surname>Methot</surname><given-names>F.</given-names></name><name name-style="western"><surname>Morand</surname><given-names>G.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva</article-title><source>Gynecol. Oncol.</source><year>1980</year><volume>10</volume><fpage>350</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/0090-8258(80)90104-3</pub-id><pub-id pub-id-type="pmid">7461500</pub-id></element-citation></ref><ref id="B5-jcm-14-06032"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Knobel</surname><given-names>J.</given-names></name><name name-style="western"><surname>van der Merwe</surname><given-names>J.V.</given-names></name></person-group><article-title>Leiomioom en leiomiosarkoom van die vulva [Leiomyoma and leiomyosarcoma of the vulva]</article-title><source>S Afr. Med. J.</source><year>1984</year><volume>66</volume><fpage>961</fpage><lpage>962</lpage><comment>(In Afrikaans)</comment><pub-id pub-id-type="pmid">6515509</pub-id></element-citation></ref><ref id="B6-jcm-14-06032"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krag M&#248;ller</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Nygaard Nielsen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Trolle</surname><given-names>C.</given-names></name></person-group><article-title>Leiomyosarcoma vulvae</article-title><source>Acta Obstet. Gynecol. Scand.</source><year>1990</year><volume>69</volume><fpage>187</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.3109/00016349009006166</pub-id><pub-id pub-id-type="pmid">2386022</pub-id></element-citation></ref><ref id="B7-jcm-14-06032"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuller</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Zucker</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>T.C.</given-names></name></person-group><article-title>Vulvar leiomyosarcoma in pregnancy</article-title><source>Am. J. Obstet. Gynecol.</source><year>1990</year><volume>162</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/0002-9378(90)90841-T</pub-id><pub-id pub-id-type="pmid">2301486</pub-id></element-citation></ref><ref id="B8-jcm-14-06032"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakri</surname><given-names>Y.N.</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>M.</given-names></name><name name-style="western"><surname>el-Senoussi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>R.</given-names></name></person-group><article-title>Vulvar sarcoma: A report of four cases</article-title><source>Gynecol. Oncol.</source><year>1992</year><volume>46</volume><fpage>384</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/0090-8258(92)90238-E</pub-id><pub-id pub-id-type="pmid">1526519</pub-id></element-citation></ref><ref id="B9-jcm-14-06032"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kapadia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Desai</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dave</surname><given-names>K.S.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva</article-title><source>Eur. J. Gynaecol. Oncol.</source><year>1993</year><volume>14</volume><fpage>406</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">8253102</pub-id></element-citation></ref><ref id="B10-jcm-14-06032"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhar</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Sau</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Dey</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vasishta</surname><given-names>K.</given-names></name></person-group><article-title>Leiomyosarcoma of the labium minus</article-title><source>Int. J. Gynaecol. Obstet.</source><year>1994</year><volume>44</volume><fpage>166</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/0020-7292(94)90074-4</pub-id><pub-id pub-id-type="pmid">7911104</pub-id></element-citation></ref><ref id="B11-jcm-14-06032"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tawfik</surname><given-names>O.</given-names></name><name name-style="western"><surname>Huntrakoon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>J.</given-names></name><name name-style="western"><surname>Owiety</surname><given-names>T.</given-names></name><name name-style="western"><surname>Seoud</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Weed</surname><given-names>J.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Leiomyosarcoma of the vulva: Report of a case</article-title><source>Gynecol. Oncol.</source><year>1994</year><volume>54</volume><fpage>242</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1006/gyno.1994.1202</pub-id><pub-id pub-id-type="pmid">8063255</pub-id></element-citation></ref><ref id="B12-jcm-14-06032"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#246;sch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Joura</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Stani</surname><given-names>J.</given-names></name><name name-style="western"><surname>Breitenecker</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lahodny</surname><given-names>J.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva, A case report</article-title><source>J. Reprod. Med.</source><year>2001</year><volume>46</volume><fpage>609</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">11441690</pub-id></element-citation></ref><ref id="B13-jcm-14-06032"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rawal</surname><given-names>N.</given-names></name><name name-style="western"><surname>Saridogan</surname><given-names>E.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Weekes</surname><given-names>A.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva in association with lichen sclerosus</article-title><source>J. Obstet. Gynaecol.</source><year>2005</year><volume>25</volume><fpage>87</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1080/01443610400025549</pub-id><pub-id pub-id-type="pmid">16147717</pub-id></element-citation></ref><ref id="B14-jcm-14-06032"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Androutsopoulos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Adonakis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ravazoula</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tsapanos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kourounis</surname><given-names>G.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva: A case report</article-title><source>Eur. J. Gynaecol. Oncol.</source><year>2005</year><volume>26</volume><fpage>577</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">16285585</pub-id></element-citation></ref><ref id="B15-jcm-14-06032"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewdney</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Galask</surname><given-names>R.P.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva: A case report</article-title><source>J. Reprod. Med.</source><year>2005</year><volume>50</volume><fpage>630</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">16220773</pub-id></element-citation></ref><ref id="B16-jcm-14-06032"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shankar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Todd</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Rytina</surname><given-names>E.</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>R.A.</given-names></name></person-group><article-title>Leiomyosarcoma of the vulva</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2006</year><volume>20</volume><fpage>116</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/j.1468-3083.2006.01341.x</pub-id><pub-id pub-id-type="pmid">16405630</pub-id></element-citation></ref><ref id="B17-jcm-14-06032"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Bugatto</surname><given-names>F.</given-names></name><name name-style="western"><surname>A&#241;&#243;n-Requena</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>L&#243;pez-Guerrero</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>B&#225;ez-Perea</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Bartha</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Herv&#237;as-Vivancos</surname><given-names>B.</given-names></name></person-group><article-title>Vulvar leiomyosarcoma in Bartholin&#8217;s gland area: A case report and literature review</article-title><source>Arch. Gynecol. Obstet.</source><year>2009</year><volume>279</volume><fpage>171</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1007/s00404-008-0652-1</pub-id><pub-id pub-id-type="pmid">18437406</pub-id></element-citation></ref><ref id="B18-jcm-14-06032"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pintilie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lane</surname><given-names>G.</given-names></name><name name-style="western"><surname>Orton</surname><given-names>J.</given-names></name><name name-style="western"><surname>El-Ghobashy</surname><given-names>A.</given-names></name></person-group><article-title>A rare case of vulval leiomyosarcoma: Management and an updated review of the literature</article-title><source>J. Obstet. Gynaecol.</source><year>2011</year><volume>31</volume><fpage>675</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.3109/01443615.2011.595519</pub-id><pub-id pub-id-type="pmid">21973156</pub-id></element-citation></ref><ref id="B19-jcm-14-06032"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levy</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Winham</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Quick</surname><given-names>C.M.</given-names></name></person-group><article-title>Smooth muscle neoplasms of the vulva masquerading as Bartholin gland duct cysts</article-title><source>Proc. (Bayl. Univ. Med. Cent.)</source><year>2014</year><volume>27</volume><fpage>25</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1080/08998280.2014.11929043</pub-id><pub-id pub-id-type="pmid">24381397</pub-id><pub-id pub-id-type="pmcid">PMC3862126</pub-id></element-citation></ref><ref id="B20-jcm-14-06032"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alnafisah</surname><given-names>F.</given-names></name><name name-style="western"><surname>Alfieri</surname><given-names>J.</given-names></name></person-group><article-title>Lung Metastasis in a Case of Recurrent Poorly Differentiated Leiomyosarcoma of the Bartholin Gland: A Case Report and Review of the Literature</article-title><source>Cureus</source><year>2016</year><volume>8</volume><fpage>e550</fpage><pub-id pub-id-type="doi">10.7759/cureus.550</pub-id><pub-id pub-id-type="pmid">27158579</pub-id><pub-id pub-id-type="pmcid">PMC4852189</pub-id></element-citation></ref><ref id="B21-jcm-14-06032"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saquib</surname><given-names>S.</given-names></name><name name-style="western"><surname>Keloth</surname><given-names>T.R.</given-names></name></person-group><article-title>Letter in Reply: Leiomyosarcoma of the Vulva Mimicking as Chronic Bartholin Cyst: A Case Report</article-title><source>Oman Med. J.</source><year>2021</year><volume>36</volume><fpage>e258</fpage><pub-id pub-id-type="doi">10.5001/omj.2021.70</pub-id><pub-id pub-id-type="pmid">33976909</pub-id><pub-id pub-id-type="pmcid">PMC8082600</pub-id></element-citation></ref><ref id="B22-jcm-14-06032"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aljehani</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Quatei</surname><given-names>A.</given-names></name><name name-style="western"><surname>Qattea</surname><given-names>L.</given-names></name><name name-style="western"><surname>Aljohani</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Alkushi</surname><given-names>A.</given-names></name></person-group><article-title>Vulvar Leiomyosarcoma in Pregnancy</article-title><source>Cureus</source><year>2021</year><volume>13</volume><fpage>e18772</fpage><pub-id pub-id-type="doi">10.7759/cureus.18772</pub-id><pub-id pub-id-type="pmid">34796063</pub-id><pub-id pub-id-type="pmcid">PMC8590387</pub-id></element-citation></ref><ref id="B23-jcm-14-06032"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinicke</surname><given-names>T.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Griggs</surname><given-names>C.</given-names></name></person-group><article-title>Vulvar Leiomyosarcoma Masquerading as a Bartholin&#8217;s Gland Cyst in an Adolescent</article-title><source>Cureus</source><year>2022</year><volume>14</volume><fpage>e21674</fpage><pub-id pub-id-type="doi">10.7759/cureus.21674</pub-id><pub-id pub-id-type="pmid">35242463</pub-id><pub-id pub-id-type="pmcid">PMC8884453</pub-id></element-citation></ref><ref id="B24-jcm-14-06032"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capalbo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Logoteta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cuccu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gentile</surname><given-names>G.</given-names></name><name name-style="western"><surname>Arienzo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Musella</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pernazza</surname><given-names>A.</given-names></name><name name-style="western"><surname>Perniola</surname><given-names>G.</given-names></name><name name-style="western"><surname>Di Donato</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Chemo-surgical approach in vulvar leiomyosarcoma: A case report</article-title><source>Tumori</source><year>2022</year><volume>108</volume><fpage>NP26</fpage><lpage>NP29</lpage><pub-id pub-id-type="doi">10.1177/03008916221130379</pub-id><pub-id pub-id-type="pmid">36239461</pub-id></element-citation></ref><ref id="B25-jcm-14-06032"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathore</surname><given-names>R.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bhatla</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mathur</surname><given-names>S.</given-names></name></person-group><article-title>Primary leiomyosarcoma of the vulva&#8212;A rare occurrence</article-title><source>Pol. J. Pathol.</source><year>2023</year><volume>74</volume><fpage>56</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.5114/pjp.2023.127293</pub-id><pub-id pub-id-type="pmid">37306354</pub-id></element-citation></ref><ref id="B26-jcm-14-06032"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.-S.</given-names></name></person-group><article-title>Dedifferentiation in uterine leiomyosarcoma: Diagnostic pitfalls and emerging molecular insights</article-title><source>Diagnostics</source><year>2024</year><volume>14</volume><elocation-id>160</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics14020160</pub-id><pub-id pub-id-type="pmid">38248037</pub-id><pub-id pub-id-type="pmcid">PMC10814992</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-14-06032-f001" orientation="portrait"><label>Figure 1</label><caption><p>Macroscopic view of the tumor: (<bold>A</bold>) 2020; (<bold>B</bold>) 2025; (<bold>C</bold>) 2025; (<bold>D</bold>) 2025.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g001.jpg"/></fig><fig position="float" id="jcm-14-06032-f002" orientation="portrait"><label>Figure 2</label><caption><p>Ultrasound of the tumor formation and lymph node. (<bold>A</bold>) Ultrasound of the tumor formation. (<bold>B</bold>) Doppler ultrasound of the tumor formation. (<bold>C</bold>) Ultrasound of the lymph node. (<bold>D</bold>) Doppler ultrasound of the lymph node.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g002.jpg"/></fig><fig position="float" id="jcm-14-06032-f003" orientation="portrait"><label>Figure 3</label><caption><p>(<bold>A</bold>) PET-CT axial section. (<bold>B</bold>) PET-CT coronal section.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g003.jpg"/></fig><fig position="float" id="jcm-14-06032-f004" orientation="portrait"><label>Figure 4</label><caption><p>(<bold>A</bold>). Intraoperative view after complete excision and bilateral lymphatic dissection. (<bold>B</bold>) Macroscopic view of the extirpated tumor. (<bold>C</bold>) Macroscopic view of the dissected tumor. (<bold>D</bold>) The 15th postoperative day.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g004.jpg"/></fig><fig position="float" id="jcm-14-06032-f005" orientation="portrait"><label>Figure 5</label><caption><p>(<bold>A</bold>) HE, 4&#215;&#8212;Cellular tumor with evidence of tumor necrosis and cellular pleomorphism. (<bold>B</bold>) HE, 10&#215;&#8212;Cellular tumor with evidence of tumor necrosis and cellular pleomorphism, scant lymphocytic infiltrate can be noticed. (<bold>C</bold>) HE 40&#215;&#8212;Significant pleomorphism and cellular atypia can be noted. (<bold>D</bold>) HE 40&#215;&#8212;Significant pleomorphism and cellular atypia are observed, single mitoses are evident.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g005.jpg"/></fig><fig position="float" id="jcm-14-06032-f006" orientation="portrait"><label>Figure 6</label><caption><p>(<bold>A</bold>) Alpha SMA, 100&#215;. (<bold>B</bold>) Desmin, 100&#215;. (<bold>C</bold>) Myo-D1, 100&#215;.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g006.jpg"/></fig><fig position="float" id="jcm-14-06032-f007" orientation="portrait"><label>Figure 7</label><caption><p>Flowchart of the literature search and selection process for the literature used in the review and discussion.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-06032-g007.jpg"/></fig><table-wrap position="float" id="jcm-14-06032-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-14-06032-t001_Table 1</object-id><label>Table 1</label><caption><p>Clinical and morphological features of patients diagnosed with VLMS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#8470;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author/Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Symptoms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Initial Tumor <break/>Size (cm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recurrence<break/>Size (cm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primary <break/>Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recurrence<break/>Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recurrence <break/>(Yes/No)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Follow-Up <break/>(months)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Metastasis</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Audet-Lapointe <break/> et al., 1980 [<xref rid="B4-jcm-14-06032" ref-type="bibr">4</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Painless growing <break/> nodule</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 &#215; 4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 &#215; 2 &#8594; 3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE, Radical <break/> Vulvectomy + BILND</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (2&#215;)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smith et al.,<break/> 1984 [<xref rid="B5-jcm-14-06032" ref-type="bibr">5</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE + RT</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KragMoller et al., <break/> 1990 [<xref rid="B6-jcm-14-06032" ref-type="bibr">6</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growing tender <break/> swelling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 &#215; 7 &#215; 4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE, Radical <break/> Vulvectomy + BILND</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kuller et al., <break/> 1990 [<xref rid="B7-jcm-14-06032" ref-type="bibr">7</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hymeneal ring, <break/> left</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 &#215; 4 &#215; 4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE, WLE, BLINK</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bakri et al., <break/> 1992 Case 1 [<xref rid="B8-jcm-14-06032" ref-type="bibr">8</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 &#215; WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (4&#215;)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bakri et al.,<break/> 1992 Case 2 [<xref rid="B8-jcm-14-06032" ref-type="bibr">8</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Painless growing <break/> nodule</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#215; 8</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 &#215; WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (3&#215;)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bakri et al., <break/> 1992 Case 3 [<xref rid="B8-jcm-14-06032" ref-type="bibr">8</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lump</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#215; 15</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 &#215; WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (2&#215;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">108- death</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bakri et al., <break/> 1992 Case 4 [<xref rid="B8-jcm-14-06032" ref-type="bibr">8</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left vulva/<break/> groin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain/swelling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 &#215; 10; <break/> 5 &#215; 3 (ILN)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE, Laparotomy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Internal <break/> iliac nodes</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patel et al., <break/> 1993 [<xref rid="B9-jcm-14-06032" ref-type="bibr">9</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radical Vulvectomy, <break/> BLINK, WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (1&#215;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dhar et al., <break/> 1994 [<xref rid="B10-jcm-14-06032" ref-type="bibr">10</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labium <break/> minus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Itching, pain</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 &#215; 6 &#215; 3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FNA ILN, <break/> Simple Vulvectomy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tawfik et al., <break/> 1994 [<xref rid="B11-jcm-14-06032" ref-type="bibr">11</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right labia <break/> majora/minora</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain, swelling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 &#215; 15</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L&#246;sch et al., <break/> 2001 [<xref rid="B12-jcm-14-06032" ref-type="bibr">12</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slowly growing <break/> mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rawal et al.,<break/> 2005 [<xref rid="B13-jcm-14-06032" ref-type="bibr">13</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lichen sclerosus over 30 yr, 1 yr postmenopausal, <break/> bleeding</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#215;2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Androutsopoulos et al., <break/> 2005 [<xref rid="B14-jcm-14-06032" ref-type="bibr">14</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right labia <break/> majora</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 yr <break/> enlargement</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8&#215;9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (Death)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dewdney et al., <break/> 2005 [<xref rid="B15-jcm-14-06032" ref-type="bibr">15</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slowly growing painless mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modified <break/> Radical Vulvectomy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shankar et al.,<break/> 2006 [<xref rid="B16-jcm-14-06032" ref-type="bibr">16</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enlarging asymptomatic<break/> lump</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gonzalez-Bugatto et <break/> al., 2009 [<xref rid="B17-jcm-14-06032" ref-type="bibr">17</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left Bartholin <break/> gland area</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Painless nodule <break/> rapid growth</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#8211;4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Excision &#8594; Hemivulvectomy+ ILND<break/> &#8594; Adjuvant RT + Chemo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">McKenzie et al., <break/> 2011 [<xref rid="B18-jcm-14-06032" ref-type="bibr">18</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right labium <break/> majus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Levy et al., <break/> 2014 Case 1 [<xref rid="B19-jcm-14-06032" ref-type="bibr">19</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labia inBartholin <break/> area</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4&#215;6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Levy et al., <break/> 2014 Case 2 [<xref rid="B19-jcm-14-06032" ref-type="bibr">19</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bartholin <break/> area</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4&#215;2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alnafisah et al., <break/> 2016 [<xref rid="B20-jcm-14-06032" ref-type="bibr">20</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rapid enlarging <break/> mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.0 &#215; 3.9 &#215; 2.9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE &#8594; Radical Vulvectomy + ILND<break/> &#8594; Chemo &#8594; Brachytherapy + EBRT</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung lobectomy + <break/> Chemo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24+</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Korkmaz et al.,<break/> 2016 [<xref rid="B2-jcm-14-06032" ref-type="bibr">2</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left vulvar Bartholin <break/> area</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enlarging vulvar <break/> mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#215; 6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saquib et al., <break/> 2020 [<xref rid="B21-jcm-14-06032" ref-type="bibr">21</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labia <break/> majora</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Painless <break/> swelling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8 &#215; 2.4&#215; 1.4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yordanov et al., 2020 <break/> [<xref rid="B3-jcm-14-06032" ref-type="bibr">3</xref>]/Present Case 2025</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73/78</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Symphysis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain, rapid <break/> growth</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 &#215; 5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15&#215;10</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Re-excision + LND</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aljehani et al., <break/> 2021 [<xref rid="B22-jcm-14-06032" ref-type="bibr">22</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38 <break/> (pregnant)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labia <break/> majora/minora</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vulvar mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 &#215; 10</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reinicke et al., <break/> 2022 [<xref rid="B23-jcm-14-06032" ref-type="bibr">23</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left labia<break/> majora</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growing mass</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 &#215; 6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Capalbo et al., <break/> 2022 [<xref rid="B24-jcm-14-06032" ref-type="bibr">24</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neoadjuvant Chemo &#8594; <break/> Radical Vulvectomy &#8594; Chemo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rathore et al., <break/> 2023 [<xref rid="B25-jcm-14-06032" ref-type="bibr">25</xref>]</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left lower of the vulva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vulvar swelling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 &#215; 8</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radical Vulvectomy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: <bold>FU</bold> = follow-up; <bold>TE</bold> = tumorectomy; <bold>WLE</bold> = wide local excision; <bold>BILND</bold> = bilateral inguinal lymph node dissection; <bold>RT</bold> = radiotherapy; <bold>ILND</bold> = inguinal lymph node dissection <bold>n.a.</bold> = not available.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>